MORGAN STANLEY PLC/CALL/PFIZER INC/52/0.1/17.01.25 | Market Closed - Börse Stuttgart 19:12:29 02/07/2024 BST | ||
| 0.014 EUR | -6.67% |
|
| 1 month | +36.36% | ||
| 3 months | -37.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 02/07/24 | 0.014 | -6.67% |
| 01/07/24 | 0.015 | 0.00% |
| 28/06/24 | 0.015 | 0.00% |
| 27/06/24 | 0.015 | +7.14% |
| 26/06/24 | 0.014 | +7.69% |
Delayed Quote Börse Stuttgart
Last update July 02, 2024 at 07:12 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | Morgan Stanley |
| WKN | MB32GP |
| ISIN | DE000MB32GP6 |
| Date issued | 01/02/2023 |
| Strike | 52 $ |
| Maturity | 17/01/2025 (199 Days) |
| Parity | 10 : 1 |
| Emission price | 0.39 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.33 € |
|---|---|
| Lowest since issue | 0.008 € |
| Spread | 0.025 € |
| Spread % | 62.50% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.83
USD
Average target price
31.92
USD
Spread / Average Target
+14.68%
- Stock Market
- Warrants
- Warrant
